Evidence map›Paper›PMID 33437230›Full record

ArticleJournal of Taibah University Medical Sciences2021

In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants.

Haruna I Umar, Sunday S Josiah, Tolulope P Saliu, Tajudeen O Jimoh, Adeola Ajayi, Jamilu B Danjuma

Open access · goldAbstract read
In one paragraph

Article in Journal of Taibah University Medical Sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Biological properties ofF1000Research · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Molecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Frontiers in chemistry · 2024
    Article
  8. In silico identification of compounds fromFrontiers in pharmacology · 2024
    Article
  9. Biochemistry research international · 2024
    Article
  10. Article
  11. Review
  12. ACS omega · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Journal of tropical medicine · 2023
    Article
  19. Phytomedicines explored underSouth African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Haruna I UmarDepartment of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria.
Sunday S JosiahDepartment of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria.
Tolulope P SaliuDepartment of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria.
Tajudeen O JimohFaculty of Pharmaceutical Sciences, Department of Pharmacognosy and Pharmaceutical Botany, Chulalongkorn University, Bangkok, Thailand.
Adeola AjayiDepartment of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria.
Jamilu B DanjumaDepartment of Biochemistry and Molecular Biology, Federal University, Birnin Kebbi, Kebbi State, Nigeria.
Federal University of Technology · NGChulalongkorn University · THFederal University Birnin Kebbi · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOver the years,

methodsThe crystal structure of Mpro was retrieved from the Protein Data Bank, while the plant bioactive compounds were retrieved from Pubchem. Drug-likeness of the selected compounds and a control drug (hydroxychloroquine) were assessed, and the compounds that satisfied the drug-likeness rule were docked against Mpro. The docked complexes were analyzed using LigPlot and the protein-ligand profiler server. The top five compound hits were subjected to ADMET screening using the ADMETSar server.

resultsA total of 17 out of 22 screened compounds passed Lipinski's assessment. Additionally, the most active compounds from the investigated plants exhibited relative inhibitory potentials against Mpro compared with hydroxychloroquine, which alludes to their possible involvement in inhibiting the SARS-CoV-2 main protease replication process.

conclusionsIn our study, most of the active phytocomponents of the investigated plants exhibited relative inhibitory potentials against Mpro of SARS-CoV-2 and preferred pharmacological features when compared with hydroxychloroquine. These findings indicate these compounds are potentially antiviral candidates against SARS-CoV-2.

Indexed as

Azadirachta indicain silicoMangifera indicaMoringa oleiferaSARS-CoV-2 main protease

Identifiers

PMID33437230
PMCPMC7787523
OpenAlexW3119543673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.